1,799
Views
26
CrossRef citations to date
0
Altmetric
Research Article

Pharmacokinetics and tissue distribution of docetaxel liposome mediated by a novel galactosylated cholesterol derivatives synthesized by lipase-catalyzed esterification in non-aqueous phase

, , , , , & show all
Pages 1282-1290 | Received 22 Sep 2014, Accepted 21 Oct 2014, Published online: 24 Nov 2014

Figures & data

Table 1. Standard curves, correlation coefficient and linear range of DOC in plasma and tissues of mice.

Table 2. The inter-(n = 5) and intra (n = 5)-day precision and recovery of the method for determination of DOC in plasma and tissues samples.

Table 3. Entrapment efficiency, particle size and zeta-potential of freshly prepared liposome suspensions.

Table 4. Pharmacokinetic parameters of DOC-i, DOC-L and G-DOC-L in rat plasma following intravenous administration (n = 5).

Figure 1. Mean plasma concentration of DOC in rat after i.v. administration of DOC-i, DOC-L and G-DOC-L at dose to 2.5 mg/kg of DOC (mean ± SD; n = 5).

Figure 1. Mean plasma concentration of DOC in rat after i.v. administration of DOC-i, DOC-L and G-DOC-L at dose to 2.5 mg/kg of DOC (mean ± SD; n = 5).

Figure 2. Concentration–time profile of DOC in heart (A), liver (B), spleen (C), lung (D), kidney (E) and plasma (F) of mice after i.v. administration of DOC-i, DOC-L and G-DOC-L at dose to 3.5 mg/kg of DOC (n = 5).

Figure 2. Concentration–time profile of DOC in heart (A), liver (B), spleen (C), lung (D), kidney (E) and plasma (F) of mice after i.v. administration of DOC-i, DOC-L and G-DOC-L at dose to 3.5 mg/kg of DOC (n = 5).

Figure 3. Concentration of DOC in heart (A), liver (B), spleen (C), lung (D), kidney (E) and plasma (F) of mice at various time points after i.v. administration of DOC-i, DOC-L and G-DOC-L at dose to 3.5 mg/kg of DOC (n = 5).

Figure 3. Concentration of DOC in heart (A), liver (B), spleen (C), lung (D), kidney (E) and plasma (F) of mice at various time points after i.v. administration of DOC-i, DOC-L and G-DOC-L at dose to 3.5 mg/kg of DOC (n = 5).

Table 5. Pharmacokinetic parameters of DOC-i, DOC-L and G-DOC-L in plasma and various tissues of mice after intravenous administration (n = 5).

Table 6. The Te (%) of DOC-i in plasma and various tissues of mice.

Table 7. Targeting parameters of DOC-L in plasma and various tissues of mice.

Table 8. Targeting parameters of G-DOC-L in plasma and various tissues of mice.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.